Toolkit/SMN tudor domain

SMN tudor domain

Protein Domain·Research·Since 2020

Also known as: SMN's globular tudor domain

Taxonomy: Mechanism Branch / Component. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

The SMN tudor domain is a globular protein domain from SMN that is sufficient for dimerization-induced condensation in vivo. Its condensate-forming activity requires binding to dimethylarginine, supporting its use as a chemical-input interaction module for specifying membraneless organelle assembly.

Usefulness & Problems

Why this is useful

This domain is useful as a compact protein module for coupling dimethylarginine recognition to condensate formation in living cells. The cited study further indicates that DMA-tudor interaction modules can regulate membraneless organelle assembly and define condensate composition.

Problem solved

The SMN tudor domain helps address the problem of how to encode chemically specified assembly of intracellular condensates using a defined protein interaction module. It provides a way to link dimethylarginine-dependent molecular recognition to dimerization-induced condensation in vivo.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Component: A low-level protein part used inside a larger architecture that realizes a mechanism.

Techniques

No technique tags yet.

Target processes

No target processes tagged yet.

Input: Chemical

Implementation Constraints

Implementation appears to rely on the isolated SMN globular tudor domain and on dimerization-induced condensation in vivo. Practical use is expected to require access to dimethylarginine-dependent binding partners or contexts in which dimethylarginine recognition can occur, but the supplied evidence does not detail construct design beyond domain sufficiency.

The available evidence is limited to a single cited study and does not provide quantitative performance metrics, construct architectures, or cross-system benchmarking. The current evidence also does not specify host organisms, expression conditions, or the extent of validation beyond in vivo condensation assays.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1generalizabilitysupports2020Source 1needs review

The condensate-forming property associated with the SMN tudor domain is shared by at least seven additional tudor domains in six different proteins.

was shared by at least seven additional tudor domains in six different proteins
additional tudor domains 7different proteins 6
Claim 2generalizabilitysupports2020Source 1needs review

The condensate-forming property associated with the SMN tudor domain is shared by at least seven additional tudor domains in six different proteins.

was shared by at least seven additional tudor domains in six different proteins
additional tudor domains 7different proteins 6
Claim 3generalizabilitysupports2020Source 1needs review

The condensate-forming property associated with the SMN tudor domain is shared by at least seven additional tudor domains in six different proteins.

was shared by at least seven additional tudor domains in six different proteins
additional tudor domains 7different proteins 6
Claim 4generalizabilitysupports2020Source 1needs review

The condensate-forming property associated with the SMN tudor domain is shared by at least seven additional tudor domains in six different proteins.

was shared by at least seven additional tudor domains in six different proteins
additional tudor domains 7different proteins 6
Claim 5generalizabilitysupports2020Source 1needs review

The condensate-forming property associated with the SMN tudor domain is shared by at least seven additional tudor domains in six different proteins.

was shared by at least seven additional tudor domains in six different proteins
additional tudor domains 7different proteins 6
Claim 6generalizabilitysupports2020Source 1needs review

The condensate-forming property associated with the SMN tudor domain is shared by at least seven additional tudor domains in six different proteins.

was shared by at least seven additional tudor domains in six different proteins
additional tudor domains 7different proteins 6
Claim 7generalizabilitysupports2020Source 1needs review

The condensate-forming property associated with the SMN tudor domain is shared by at least seven additional tudor domains in six different proteins.

was shared by at least seven additional tudor domains in six different proteins
additional tudor domains 7different proteins 6
Claim 8mechanistic rolesupports2020Source 1needs review

A tudor domain bound to dimethylarginine constitutes a versatile yet specific interaction module that regulates membraneless organelle assembly and defines composition.

the combination of a tudor domain bound to its DMA ligand – DMA-tudor – represents a versatile yet specific interaction module that regulates MLO assembly and defines their composition
Claim 9mechanistic rolesupports2020Source 1needs review

A tudor domain bound to dimethylarginine constitutes a versatile yet specific interaction module that regulates membraneless organelle assembly and defines composition.

the combination of a tudor domain bound to its DMA ligand – DMA-tudor – represents a versatile yet specific interaction module that regulates MLO assembly and defines their composition
Claim 10mechanistic rolesupports2020Source 1needs review

A tudor domain bound to dimethylarginine constitutes a versatile yet specific interaction module that regulates membraneless organelle assembly and defines composition.

the combination of a tudor domain bound to its DMA ligand – DMA-tudor – represents a versatile yet specific interaction module that regulates MLO assembly and defines their composition
Claim 11mechanistic rolesupports2020Source 1needs review

A tudor domain bound to dimethylarginine constitutes a versatile yet specific interaction module that regulates membraneless organelle assembly and defines composition.

the combination of a tudor domain bound to its DMA ligand – DMA-tudor – represents a versatile yet specific interaction module that regulates MLO assembly and defines their composition
Claim 12mechanistic rolesupports2020Source 1needs review

A tudor domain bound to dimethylarginine constitutes a versatile yet specific interaction module that regulates membraneless organelle assembly and defines composition.

the combination of a tudor domain bound to its DMA ligand – DMA-tudor – represents a versatile yet specific interaction module that regulates MLO assembly and defines their composition
Claim 13mechanistic rolesupports2020Source 1needs review

A tudor domain bound to dimethylarginine constitutes a versatile yet specific interaction module that regulates membraneless organelle assembly and defines composition.

the combination of a tudor domain bound to its DMA ligand – DMA-tudor – represents a versatile yet specific interaction module that regulates MLO assembly and defines their composition
Claim 14mechanistic rolesupports2020Source 1needs review

A tudor domain bound to dimethylarginine constitutes a versatile yet specific interaction module that regulates membraneless organelle assembly and defines composition.

the combination of a tudor domain bound to its DMA ligand – DMA-tudor – represents a versatile yet specific interaction module that regulates MLO assembly and defines their composition
Claim 15requirementsupports2020Source 1needs review

The condensate-forming property of the SMN tudor domain requires binding to dimethylarginine.

The condensate-forming property of the SMN tudor domain required binding to its ligand, dimethylarginine (DMA)
Claim 16requirementsupports2020Source 1needs review

The condensate-forming property of the SMN tudor domain requires binding to dimethylarginine.

The condensate-forming property of the SMN tudor domain required binding to its ligand, dimethylarginine (DMA)
Claim 17requirementsupports2020Source 1needs review

The condensate-forming property of the SMN tudor domain requires binding to dimethylarginine.

The condensate-forming property of the SMN tudor domain required binding to its ligand, dimethylarginine (DMA)
Claim 18requirementsupports2020Source 1needs review

The condensate-forming property of the SMN tudor domain requires binding to dimethylarginine.

The condensate-forming property of the SMN tudor domain required binding to its ligand, dimethylarginine (DMA)
Claim 19requirementsupports2020Source 1needs review

The condensate-forming property of the SMN tudor domain requires binding to dimethylarginine.

The condensate-forming property of the SMN tudor domain required binding to its ligand, dimethylarginine (DMA)
Claim 20requirementsupports2020Source 1needs review

The condensate-forming property of the SMN tudor domain requires binding to dimethylarginine.

The condensate-forming property of the SMN tudor domain required binding to its ligand, dimethylarginine (DMA)
Claim 21requirementsupports2020Source 1needs review

The condensate-forming property of the SMN tudor domain requires binding to dimethylarginine.

The condensate-forming property of the SMN tudor domain required binding to its ligand, dimethylarginine (DMA)
Claim 22specificity controlsupports2020Source 1needs review

Asymmetric versus symmetric dimethylarginine determines whether gems and Cajal bodies are separate or overlapping.

asymmetric versus symmetric DMA determined whether two distinct nuclear MLOs – gems and Cajal bodies – were separate or overlapping
Claim 23specificity controlsupports2020Source 1needs review

Asymmetric versus symmetric dimethylarginine determines whether gems and Cajal bodies are separate or overlapping.

asymmetric versus symmetric DMA determined whether two distinct nuclear MLOs – gems and Cajal bodies – were separate or overlapping
Claim 24specificity controlsupports2020Source 1needs review

Asymmetric versus symmetric dimethylarginine determines whether gems and Cajal bodies are separate or overlapping.

asymmetric versus symmetric DMA determined whether two distinct nuclear MLOs – gems and Cajal bodies – were separate or overlapping
Claim 25specificity controlsupports2020Source 1needs review

Asymmetric versus symmetric dimethylarginine determines whether gems and Cajal bodies are separate or overlapping.

asymmetric versus symmetric DMA determined whether two distinct nuclear MLOs – gems and Cajal bodies – were separate or overlapping
Claim 26specificity controlsupports2020Source 1needs review

Asymmetric versus symmetric dimethylarginine determines whether gems and Cajal bodies are separate or overlapping.

asymmetric versus symmetric DMA determined whether two distinct nuclear MLOs – gems and Cajal bodies – were separate or overlapping
Claim 27specificity controlsupports2020Source 1needs review

Asymmetric versus symmetric dimethylarginine determines whether gems and Cajal bodies are separate or overlapping.

asymmetric versus symmetric DMA determined whether two distinct nuclear MLOs – gems and Cajal bodies – were separate or overlapping
Claim 28specificity controlsupports2020Source 1needs review

Asymmetric versus symmetric dimethylarginine determines whether gems and Cajal bodies are separate or overlapping.

asymmetric versus symmetric DMA determined whether two distinct nuclear MLOs – gems and Cajal bodies – were separate or overlapping
Claim 29sufficiencysupports2020Source 1needs review

The SMN tudor domain is sufficient for dimerization-induced condensation in vivo.

SMN’s globular tudor domain was sufficient for dimerization-induced condensation in vivo
Claim 30sufficiencysupports2020Source 1needs review

The SMN tudor domain is sufficient for dimerization-induced condensation in vivo.

SMN’s globular tudor domain was sufficient for dimerization-induced condensation in vivo
Claim 31sufficiencysupports2020Source 1needs review

The SMN tudor domain is sufficient for dimerization-induced condensation in vivo.

SMN’s globular tudor domain was sufficient for dimerization-induced condensation in vivo
Claim 32sufficiencysupports2020Source 1needs review

The SMN tudor domain is sufficient for dimerization-induced condensation in vivo.

SMN’s globular tudor domain was sufficient for dimerization-induced condensation in vivo
Claim 33sufficiencysupports2020Source 1needs review

The SMN tudor domain is sufficient for dimerization-induced condensation in vivo.

SMN’s globular tudor domain was sufficient for dimerization-induced condensation in vivo
Claim 34sufficiencysupports2020Source 1needs review

The SMN tudor domain is sufficient for dimerization-induced condensation in vivo.

SMN’s globular tudor domain was sufficient for dimerization-induced condensation in vivo
Claim 35sufficiencysupports2020Source 1needs review

The SMN tudor domain is sufficient for dimerization-induced condensation in vivo.

SMN’s globular tudor domain was sufficient for dimerization-induced condensation in vivo

Approval Evidence

1 source3 linked approval claimsfirst-pass slug smn-tudor-domain
SMN’s globular tudor domain was sufficient for dimerization-induced condensation in vivo

Source:

generalizabilitysupports

The condensate-forming property associated with the SMN tudor domain is shared by at least seven additional tudor domains in six different proteins.

was shared by at least seven additional tudor domains in six different proteins

Source:

requirementsupports

The condensate-forming property of the SMN tudor domain requires binding to dimethylarginine.

The condensate-forming property of the SMN tudor domain required binding to its ligand, dimethylarginine (DMA)

Source:

sufficiencysupports

The SMN tudor domain is sufficient for dimerization-induced condensation in vivo.

SMN’s globular tudor domain was sufficient for dimerization-induced condensation in vivo

Source:

Comparisons

Source-backed strengths

The domain was reported to be sufficient for dimerization-induced condensation in vivo, indicating that the globular tudor domain alone can confer this behavior. The underlying interaction logic is supported by evidence that condensate formation requires dimethylarginine binding, and related condensate-forming behavior was observed for at least seven additional tudor domains in six proteins.

Ranked Citations

  1. 1.

    Extracted from this source document.